四剂狂犬病疫苗预防狂犬病
随机、盲法和阳性对照设计:评估 5 剂冻干狂犬病疫苗(Vero 细胞)批次与 4 剂疫苗的免疫原性和安全性的一致性的 III 期临床试验 (1-1-1-1) )
To evaluate the non inferiority of the immunogenicity of the test vaccine inoculated according to the four dose immunization program over the five dose immunization program and the batches consistency of immunogenicity according to five dose immunization procedures.
研究概览
详细说明
- In the population aged 10-60 years, evaluate the non inferiority of the immunogenicity of the test vaccine inoculated according to the four dose immunization program (0, 3, 7, 14/28 days) over the five dose immunization program (0, 3, 7, 14, 28 days);
- To evaluate the consistency of immunogenicity between batches of freeze-dried human rabies vaccine (Vero cell) inoculated according to five dose immunization procedures (0, 3, 7, 14, 28 days).
研究类型
注册 (实际的)
阶段
- 第三阶段
联系人和位置
学习地点
-
-
Jilin
-
Changchun、Jilin、中国、130000
- Changchun Zhuoyi Biological Co., Ltd
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- People aged 10-60;
- Body temperature on the day of enrollment<37.3℃ (axillary temperature)
Exclusion Criteria:
- Have a history of rabies vaccine immunization or use of rabies virus passive immunization agents;
- People with congenital or acquired immunodeficiency or other autoimmune diseases;
- Female urine pregnancy test is positive, or during pregnancy and lactation, or she has a birth plan during the study period;
学习计划
研究是如何设计的?
设计细节
- 主要用途:预防
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:双倍的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:4 doses
Inoculate rabies vaccine according to 1-1-1-1 immunization procedure |
The subjects were vaccinated with rabies vaccine according to different immunization procedures |
|
实验性的:5 doses
Inoculate rabies vaccine according to 1-1-1-1-1 immunization procedure |
The subjects were vaccinated with rabies vaccine according to different immunization procedures |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Positive conversion rate of 14 days
大体时间:6 months
|
- 14 days after the first dose of inoculation, the positive conversion rate of serum neutralizing antibody. |
6 months
|
|
Antibody Geometric Mean Titer (GMT) of 14 days
大体时间:6 months
|
- 14 days after the first dose of inoculation, the Geometric Mean Titer (GMT) of serum neutralizing antibody . |
6 months
|
|
Positive conversion rate of 42 days
大体时间:6 months
|
- The seroconversion rate of serum neutralizing antibody that 42 days after the first dose of inoculation. |
6 months
|
|
Advertise Events (AE) incidence within 1 month
大体时间:6 months
|
- The distribution of AE incidence in different time periods (including all, within 30 minutes, 0-3 days, 0-7 days, 8-30 days) after each dose of inoculation; |
6 months
|
|
Serious Adverse Events (SAE) incidence within 6 months
大体时间:12 months
|
- Incidence rate of SAE within 6 months from the first dose of inoculation to the full course of inoculation. |
12 months
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Antibody test of 28 days
大体时间:6 months
|
Detection of serum neutralizing antibody 28 days after the first dose of inoculation |
6 months
|
|
Antibody GMT of 42 days
大体时间:6 months
|
The serum neutralized antibody GMT 42 days after the first dose of inoculation; |
6 months
|
|
Antibody test within 12 months
大体时间:18months
|
The serum neutralizing antibody was detected in 3 timepoints within 12 months after the whole vaccination. |
18months
|
合作者和调查者
调查人员
- 研究主任:Li Miao、Changchun Zhuoyi Biological Co., Ltd
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- ZY202106001
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
safety and antibody results.
IPD 共享时间框架
before December 2024.
IPD 共享访问标准
public to all.
IPD 共享支持信息类型
- 研究方案
- 国际碳纤维联合会
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.